European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when | Haematologica
Fehérjebiotechnológia
Prognostic Stratification of Multiple Myeloma Using Clinicog... : HemaSphere
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group | Blood Cancer Journal
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group | Blood Cancer Journal
Display of a 47-year-old male (patient #10) with multiple myeloma R-ISS... | Download Scientific Diagram
Prognostic Stratification of Multiple Myeloma Using Clinicog... : HemaSphere
Prognostic Stratification of Multiple Myeloma Using Clinicog... : HemaSphere
Prognostic Stratification of Multiple Myeloma Using Clinicog... : HemaSphere
Fehérjebiotechnológia
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT | Blood Cancer Journal
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group | Blood Cancer Journal
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT | Blood Cancer Journal
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group | Blood Cancer Journal
Display of a 47-year-old male (patient #10) with multiple myeloma R-ISS... | Download Scientific Diagram
Doktori (PhD) értekezés
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT | Blood Cancer Journal
Fehérjebiotechnológia
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma | Nature Communications
Doktori (PhD) értekezés
Trogarzo, INN-ibalizumab
